Free Guide to Understanding Glucose Monitor Coverage

How Glucose Monitors Work and Why Coverage Matters

A glucose monitor is a medical device that measures blood sugar levels throughout the day. There are two main types: traditional fingerstick meters and continuous glucose monitors (CGMs). Fingerstick meters require you to prick your finger, place a small drop of blood on a test strip, and insert it into a handheld device that displays your blood sugar reading within seconds. Continuous glucose monitors use a small sensor worn on your skin—typically on the abdomen or arm—that checks glucose levels every few minutes automatically and sends readings to a receiver or smartphone app.

Your Free Email Password Management Guide →

Understanding how these devices work helps explain why insurance coverage differs. CGMs, for example, cost significantly more upfront than fingerstick supplies but may reduce the number of manual checks needed daily. A person with type 1 diabetes might use 4-10 fingerstick tests per day, while someone using a CGM might test only 1-2 times daily for calibration purposes. The total cost of supplies varies widely: fingerstick test strips typically cost $0.50 to $2.00 per strip without insurance, while CGM sensors can cost $50-$300 per sensor depending on the brand.

Insurance plans make coverage decisions based on several factors: the type of diabetes diagnosis, current glucose control levels, frequency of hypoglycemic episodes, and whether other treatments have been tried first. Medicare covers CGMs for people with diabetes who take insulin, but coverage rules differ for those using other medications. Private insurers have their own policies. Understanding these distinctions matters because they determine what you might pay out-of-pocket and which devices may be covered under your specific plan.

Practical takeaway: Before discussing coverage options with your insurance provider, write down which type of glucose monitor you currently use or are considering (fingerstick meter, traditional CGM like Dexcom, Freestyle Libre, or Medtronic, or newer models). Know your diabetes medication type—insulin users and non-insulin users often face different coverage scenarios. This information will help you have more focused conversations about what your plan covers.

Medicare Coverage for Glucose Monitoring Supplies

Medicare Part B covers glucose monitoring supplies for people with diabetes, but the coverage structure depends on whether you use insulin and which device you choose. As of 2024, Medicare covers continuous glucose monitors (CGMs) for beneficiaries who use insulin. Specifically, people taking insulin—whether through injections or a pump—can receive coverage for a CGM system, including the sensor, transmitter, and receiver. The program classifies these as durable medical equipment (DME), meaning Medicare pays 80% of the approved amount after you meet your Part B deductible, and you pay the remaining 20%.

Get Your Free Cumberland Maryland Unemployment Office Locations Guide →

For traditional fingerstick glucose meters, Medicare coverage applies to all people with diabetes regardless of medication type. The program covers the meter itself and test strips. Medicare typically covers 100 strips and lancets per month for people not using insulin, and up to 100 strips and lancets per month for insulin users, though some beneficiaries using intensive insulin therapy may receive additional supplies. The actual coverage amount depends on competitive bidding outcomes in your geographic region, as Medicare contracts with specific suppliers in different areas.

Understanding the enrollment process matters for Medicare beneficiaries. You don't submit an application through Medicare directly for most glucose supplies. Instead, you work with a Medicare-approved DME supplier. Your doctor must provide a prescription or written order, and the supplier verifies your Medicare coverage. For CGMs specifically, your healthcare provider may need to document that you meet medical necessity criteria—typically that you take insulin and have had difficulty controlling blood sugar or experience frequent low blood sugar episodes.

The monthly costs for Medicare beneficiaries vary significantly. Someone with a Medigap supplemental plan that covers the 20% coinsurance might pay nothing after their deductible. Someone with Original Medicare and no supplemental coverage pays 20% of the approved amount. A person using multiple insurance types—for example, someone under 65 with a group health plan who also receives Medicare due to disability—may have coordination of benefits rules that affect which plan pays first.

Practical takeaway: If you have Medicare, call 1-800-MEDICARE to confirm your current Part B coverage details and learn which DME suppliers serve your area. Ask specifically whether your coverage includes CGM or only fingerstick supplies. Request a list of approved suppliers, then contact 2-3 suppliers to compare their ordering process and delivery times. Some suppliers offer faster shipping or better customer service than others, which affects how quickly you receive replacement supplies.

Private Insurance Plans and Coverage Variations

Private health insurance coverage for glucose monitors varies significantly between plans and insurers. Unlike Medicare, which has standardized national rules, each private insurance plan sets its own coverage policies. Some plans cover CGMs as preferred devices with minimal out-of-pocket costs, while others require patients to try fingerstick meters first or classify CGMs as non-covered services. The variation reflects different insurer strategies about which devices provide the most cost-effective outcomes.

Learn About Diabetes Device Trials in 2026 →

Major insurers like UnitedHealthcare, Aetna, Anthem, and Cigna each maintain different coverage policies. UnitedHealthcare, for example, may cover certain CGM brands for people meeting specific criteria while excluding others. Aetna might require prior authorization—a pre-approval from your doctor stating medical necessity—before covering a CGM. Anthem may apply different rules depending on whether you have a preferred provider organization (PPO) plan, health maintenance organization (HMO) plan, or high-deductible health plan (HDHP). This means two people with the same diagnosis at the same employer might have different coverage if they chose different plan options during enrollment.

Employer-sponsored plans often have different coverage from marketplace plans purchased through healthcare.gov or your state's health insurance marketplace. Someone enrolled in an employer plan might pay a copay (fixed amount like $30) for a month of supplies, while someone on a marketplace plan might pay coinsurance (percentage like 20%) on the full cost. This distinction matters because a $150 copay feels very different from potentially owing 20% of a $1,000 monthly supply cost.

Coverage also often depends on specific diagnoses and circumstances. Some plans cover CGMs only for people with type 1 diabetes but not type 2 diabetes, reflecting an assumption that type 1 patients benefit more from continuous monitoring. Others extend coverage to type 2 patients on insulin. Plans may also cover CGMs for people who experience hypoglycemic unawareness (inability to sense low blood sugar symptoms) or those who have had repeated hospitalizations for blood sugar emergencies. These medical necessity criteria exist because insurers use them to manage costs.

Practical takeaway: Contact your insurance plan directly—not through your employer's HR department, but through the customer service number on your insurance card. Ask three specific questions: (1) Does my plan cover continuous glucose monitors, and if so, which brands? (2) Is prior authorization required? (3) What is my out-of-pocket cost—copay, coinsurance, or deductible? Request written confirmation via email or mail. Write down the date, time, and representative's name for your records. This documentation helps if there are billing disputes later.

State Programs and Medicaid Coverage Rules

Medicaid coverage for glucose monitoring supplies follows federal guidelines but varies by state because each state administers its own Medicaid program. Federally, Medicaid must cover glucose monitors and supplies for people with diabetes, but states determine the specific products covered, the quantities allowed, and any prior authorization requirements. This creates a patchwork of coverage across the country: someone in New York might have access to multiple CGM brands through Medicaid, while someone in another state might only have fingerstick coverage readily available.

Learn About Getting a Birth Certificate in Pennsylvania →

Most states cover traditional fingerstick glucose meters and test strips through Medicaid for all eligible beneficiaries with diabetes. Coverage typically includes 100-150 test strips per month depending on your state and whether you use insulin. More than half of states now cover continuous glucose monitors through Medicaid, but often with restrictions. Some states cover CGMs for people with type 1 diabetes and insulin-using type 2 diabetes patients but may require prior authorization documenting that the person has poor glucose control despite regular testing or experiences frequent hypoglycemic episodes.

Specific state examples show this variation clearly. California's Medicaid program covers multiple CGM brands including Dexcom, Freestyle Libre, and Medtronic Guardian for both type 1 and type 2 diabetes patients meeting medical necessity criteria. Texas covers CGMs for type 1